Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.

Lei Y, Zhao X, Huang H, Duan L, Xu J, Miao K, Zhao H, Qiao C, Hong M, Qian S, Fan L, Zhu Y

Open source

DOI: 10.1177/20406207261480378
Published: 2026
Container: Therapeutic advances in hematology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/20406207261480378,
  title = {Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.},
  author = {Lei Y and Zhao X and Huang H and Duan L and Xu J and Miao K and Zhao H and Qiao C and Hong M and Qian S and Fan L and Zhu Y},
  year = {2026},
  journal = {Therapeutic advances in hematology},
  doi = {10.1177/20406207261480378},
  url = {https://doi.org/10.1177/20406207261480378}
}

RIS

TY  - JOUR
TI  - Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.
AU  - Lei Y
AU  - Zhao X
AU  - Huang H
AU  - Duan L
AU  - Xu J
AU  - Miao K
AU  - Zhao H
AU  - Qiao C
AU  - Hong M
AU  - Qian S
AU  - Fan L
AU  - Zhu Y
PY  - 2026
JO  - Therapeutic advances in hematology
DO  - 10.1177/20406207261480378
UR  - https://doi.org/10.1177/20406207261480378
ER  -

APA

Y, L., X, Z., H, H., L, D., J, X., K, M., H, Z., C, Q., M, H., S, Q., L, F., & Y, Z. (2026). Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.. Therapeutic advances in hematology. https://doi.org/10.1177/20406207261480378

Source records

pubmed · retrieved 2026-09-26T15:54:53.528Z
europe-pmc · retrieved 2026-09-26T15:54:53.538Z
doaj · retrieved 2026-09-26T15:54:53.532Z